mTNX-1700 (mTFF2-MSA) suppresses tumor growth and increases survival rates in preclinical colorectal cancer models mTNX-1700 shows single agent activity and…
– Initiation of Phase 1 clinical trial marks Entrada’s transition into a clinical company – – Data anticipated in the…
CHICAGO, IL / ACCESSWIRE / September 20, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…
First Sustainability Report since becoming an independent company in January 2023 underscores the Company’s commitment to corporate responsibility and embodies…
John Nicols brings 30+ years of experience growing biotechnology and specialty chemical companiesBOHEMIA, NY / ACCESSWIRE / September 20, 2023…
Patent issuance expands U.S. patent portfolio for AVERSA™ transdermal abuse deterrent technologyORLANDO, FL / ACCESSWIRE / September 20, 2023 /…
Company’s Chief Medical Officer and FDA veteran receives distinguished award for notable contributions to clinical researchDURHAM, N.C., Sept. 20, 2023…
BOSTON and ATLANTA, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical…
NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- via IBN — Lucy Scientific Discovery (NASDAQ: LSDI) today announces its placement…
MIAMI, FL, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…